On October 16, 2020, Telcon RF Pharmaceutical Inc. (KOSDAQ:A200230) closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
775 KRW | -1.02% | +4.59% | -11.23% |
1st Jan change | Capi. | |
---|---|---|
-11.23% | 63.68M | |
-7.01% | 193B | |
+8.94% | 82.63B | |
+62.04% | 67.28B | |
+8.32% | 57.93B | |
+12.39% | 27.89B | |
+11.78% | 20.39B | |
+65.01% | 20.39B | |
+8.27% | 17.71B | |
-10.92% | 17.23B |
- Stock Market
- Equities
- A200230 Stock
- News TELCON RF PHARMACEUTICAL. Inc.
- Telcon RF Pharmaceutical Inc. announced that it has received KRW 30 billion in funding from Emmaus Life Sciences, Inc.